Figure 1.
Figure 1. The somatic mutations detected in HLA−granulocytes. (A) A summary of targeted sequencing of the 15 cases. Somatic mutations (red), nonsynonymous mutations of unknown significance (green), and synonymous mutations (pink) are shown. (B) The somatic mutations in HLA− granulocytes and HLA+ granulocytes (left, DNMT3A, ZRSR2 and TET2 mutations in case 1; top right, a DNMT3A mutation in case 2; bottom right, a CBL mutation in case 4). HLA+ granulocytes of cases 2 and 3 were not assessable due to the paucity of the cell populations. Two different TET2 frameshift mutations were detected in case 1’s HLA− granulocytes and HLA+ granulocytes, respectively. (C) The somatic mutations detected by whole-exome sequencing (WES) in 5 cases. del., deletion.

The somatic mutations detected in HLAgranulocytes. (A) A summary of targeted sequencing of the 15 cases. Somatic mutations (red), nonsynonymous mutations of unknown significance (green), and synonymous mutations (pink) are shown. (B) The somatic mutations in HLA granulocytes and HLA+ granulocytes (left, DNMT3A, ZRSR2 and TET2 mutations in case 1; top right, a DNMT3A mutation in case 2; bottom right, a CBL mutation in case 4). HLA+ granulocytes of cases 2 and 3 were not assessable due to the paucity of the cell populations. Two different TET2 frameshift mutations were detected in case 1’s HLA granulocytes and HLA+ granulocytes, respectively. (C) The somatic mutations detected by whole-exome sequencing (WES) in 5 cases. del., deletion.

Close Modal

or Create an Account

Close Modal
Close Modal